Epidemiology of colonic symptoms and the irritable bowel syndrome.

PubWeight™: 3.90‹?› | Rank: Top 1%

🔗 View Article (PMID 1889716)

Published in Gastroenterology on October 01, 1991

Authors

N J Talley1, A R Zinsmeister, C Van Dyke, L J Melton

Author Affiliations

1: Division of Gastroenterology, Mayo Clinic and Foundation, Rochester, Minnesota.

Associated clinical trials:

Use of Functional Magnetic Resonance Imaging (fMRI) to Study Brain Activation in Children With Irritable Bowel Syndrome (fMRI) | NCT00677976

Efficacy and Safety of SYN-010 in IBS-C | NCT03763175

Articles citing this

(truncated to the top 100)

Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut (2007) 3.87

Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut (2008) 2.77

Sex differences in irritable bowel syndrome in Japanese university students. J Gastroenterol (2006) 2.23

British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut (2000) 2.09

Effect of cholecystectomy on bowel function: a prospective, controlled study. Gut (1999) 2.08

The epidemiology of irritable bowel syndrome. Clin Epidemiol (2014) 2.06

Non-enteric infections, antibiotic use, and risk of development of functional gastrointestinal disorders. Neurogastroenterol Motil (2015) 1.99

Predictors of health care seeking for irritable bowel syndrome: a population based study. Gut (1997) 1.95

Reasons for consultation in irritable bowel syndrome: symptoms and patient characteristics. Br J Gen Pract (1992) 1.75

Intestinal transit in anxiety and depression. Gut (1996) 1.67

IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci (2004) 1.53

Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol (2008) 1.52

Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population. Gut (1998) 1.48

Psychosocial distress and somatic symptoms in community subjects with irritable bowel syndrome: a psychological component is the rule. Am J Gastroenterol (2009) 1.46

Psychosocial risk markers for new onset irritable bowel syndrome--results of a large prospective population-based study. Pain (2007) 1.42

Are the definitions for chronic diarrhoea adequate? Evaluation of two different definitions in patients with chronic diarrhoea. United European Gastroenterol J (2015) 1.40

Evidence Against Routine Testing of Patients With Functional Gastrointestinal Disorders for Celiac Disease: A Population-based Study. Clin Gastroenterol Hepatol (2015) 1.40

Familial aggregation of irritable bowel syndrome: a prospective study. Gut (2003) 1.33

Do patients with irritable bowel syndrome in primary care really differ from outpatients with irritable bowel syndrome? Gut (1997) 1.31

Functional bowel disorders in Iranian population using Rome III criteria. Saudi J Gastroenterol (2010) 1.30

Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation. Neurogastroenterol Motil (2014) 1.19

Discriminant value of psychological distress, symptom profiles, and segmental colonic dysfunction in outpatients with severe idiopathic constipation. Gut (1994) 1.19

Meta-analysis: do irritable bowel syndrome symptoms vary between men and women? Aliment Pharmacol Ther (2010) 1.14

Epidemiology of irritable bowel syndrome in Chinese. Dig Dis Sci (2002) 1.12

Low socioeconomic class is a risk factor for upper and lower gastrointestinal symptoms: a population based study in 15 000 Australian adults. Gut (2001) 1.11

Psychopathology in irritable bowel syndrome: support for a psychophysiological model. J Behav Med (2003) 1.10

Prevalence and risk factors for abdominal bloating and visible distention: a population-based study. Gut (2008) 1.09

Irritable bowel syndrome subtypes differ in body awareness, psychological symptoms and biochemical stress markers. World J Gastroenterol (2008) 1.09

Prevalence of depression and anxiety in irritable bowel syndrome: A clinic based study from India. Indian J Psychiatry (2013) 1.07

The relationship between daily life stress and gastrointestinal symptoms in women with irritable bowel syndrome. J Behav Med (1997) 1.06

Long-term safety and effectiveness of lubiprostone, a chloride channel (ClC-2) activator, in patients with chronic idiopathic constipation. Dig Dis Sci (2011) 1.06

Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial. J Gastroenterol (1997) 1.04

Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver (2015) 1.03

Sleep, immunity and inflammation in gastrointestinal disorders. World J Gastroenterol (2013) 1.02

Overlap of dyspepsia and gastroesophageal reflux in the general population: one disease or distinct entities? Neurogastroenterol Motil (2011) 1.01

Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome. Gut Liver (2011) 0.99

Factors associated with persistent and nonpersistent chronic constipation, over 20 years. Clin Gastroenterol Hepatol (2012) 0.98

Abnormal propagation pattern of duodenal pressure waves in the irritable bowel syndrome (IBS) [correction of (IBD)]. Dig Dis Sci (2000) 0.98

Italian consensus conference for colonic diverticulosis and diverticular disease. United European Gastroenterol J (2014) 0.97

Body awareness therapy: a new strategy for relief of symptoms in irritable bowel syndrome patients. World J Gastroenterol (2007) 0.97

Gender Role in Irritable Bowel Syndrome: A Comparison of Irritable Bowel Syndrome Module (ROME III) Between Male and Female Patients. J Neurogastroenterol Motil (2012) 0.96

Pain symptoms and stooling patterns do not drive diagnostic costs for children with functional abdominal pain and irritable bowel syndrome in primary or tertiary care. Pediatrics (2009) 0.96

Treating irritable bowel syndrome: overview, perspective and future therapies. Br J Pharmacol (2004) 0.96

Laparoscopic total colectomy for colonic inertia: surgical and functional results. Surg Endosc (2008) 0.95

Effects and possible mechanisms of acupuncture at ST36 on upper and lower abdominal symptoms induced by rectal distension in healthy volunteers. Am J Physiol Regul Integr Comp Physiol (2012) 0.95

Effect of red pepper on symptoms of irritable bowel syndrome: preliminary study. Dig Dis Sci (2011) 0.95

Bowel function and irritable bowel symptoms after hysterectomy and cholecystectomy--a population based study. Gut (1993) 0.94

Recollection of childhood abdominal pain in adults with functional gastrointestinal disorders. Scand J Gastroenterol (2009) 0.94

Effect of probiotics on symptoms in korean adults with irritable bowel syndrome. Gut Liver (2009) 0.92

Prevalence and factors associated with irritable bowel syndrome among medical students of Karachi, Pakistan: a cross-sectional study. BMC Res Notes (2012) 0.92

Opioid bowel dysfunction and narcotic bowel syndrome: a population-based study. Am J Gastroenterol (2009) 0.92

Lubiprostone for the treatment of adults with constipation and irritable bowel syndrome. Dig Dis Sci (2011) 0.91

Prevalence and risk factors for dysphagia: a USA community study. Neurogastroenterol Motil (2014) 0.90

The development of a sexual abuse severity score: characteristics of childhood sexual abuse associated with trauma symptomatology, somatization, and alcohol abuse. J Interpers Violence (2008) 0.90

Estimating the contribution of acute gastroenteritis to the overall prevalence of irritable bowel syndrome. J Neurogastroenterol Motil (2012) 0.90

A 14-day elemental diet is highly effective in normalizing the lactulose breath test. Dig Dis Sci (2004) 0.90

Gastrointestinal symptoms in a Japanese population: a health diary study. World J Gastroenterol (2007) 0.89

High prevalence of irritable bowel syndrome in patients attending urological outpatient departments. Dig Dis Sci (1997) 0.89

Ambulatory abdominal inductance plethysmography: towards objective assessment of abdominal distension in irritable bowel syndrome. Gut (2001) 0.89

Testing the sensitivity hypothesis in practice: tools and methods, assumptions and pitfalls. Gut (2002) 0.88

Electroacupuncture for patients with diarrhea-predominant irritable bowel syndrome or functional diarrhea: A randomized controlled trial. Medicine (Baltimore) (2016) 0.85

Melatonin for the treatment of irritable bowel syndrome. World J Gastroenterol (2014) 0.84

A survey of irritable bowel syndrome in Vietnam using the Rome criteria. Dig Dis Sci (2006) 0.84

Early life adversity as a risk factor for visceral pain in later life: importance of sex differences. Front Neurosci (2013) 0.84

The treatment of irritable bowel syndrome. Therap Adv Gastroenterol (2009) 0.84

Irritable bowel syndrome in a Bangladeshi urban community: prevalence and health care seeking pattern. Saudi J Gastroenterol (2009) 0.84

Inclusion criteria for pharmacodynamic and clinical trials in chronic idiopathic constipation: pitfalls in using Rome III for functional constipation. Therap Adv Gastroenterol (2011) 0.83

Novel pharmacology: asimadoline, a kappa-opioid agonist, and visceral sensation. Neurogastroenterol Motil (2008) 0.83

Irritable bowel syndrome and chronic pelvic pain: a singular or two different clinical syndrome? World J Gastroenterol (2007) 0.83

Biliary events and an increased risk of new onset irritable bowel syndrome: a population-based cohort study. Aliment Pharmacol Ther (2008) 0.83

Allergic mastocytic gastroenteritis and colitis: an unexplained etiology in chronic abdominal pain and gastrointestinal dysmotility. Gastroenterol Res Pract (2012) 0.83

Open-label treatment with citalopram in patients with irritable bowel syndrome: a pilot study. Prim Care Companion J Clin Psychiatry (2005) 0.82

From comic relief to real understanding; how intestinal gas causes symptoms. Gut (2003) 0.82

Patients treated by tegaserod for irritable bowel syndrome with constipation showed significant improvement in fibromyalgia symptoms. A pilot study. Clin Rheumatol (2009) 0.82

Patients with irritable bowel syndrome: health status and use of health care services. Br J Gen Pract (1999) 0.82

Genes and irritable bowel syndrome: is there a link? Curr Gastroenterol Rep (2008) 0.82

Pathophysiology and management of irritable bowel syndrome. Korean J Intern Med (2001) 0.81

Health care seeking for abdominal bloating and visible distention. Aliment Pharmacol Ther (2009) 0.81

Resource utilization associated with irritable bowel syndrome in the United States 1987-1997. Dig Dis Sci (2002) 0.81

Role of anxiety in the pathophysiology of irritable bowel syndrome: importance of the amygdala. Front Neurosci (2009) 0.80

Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization. Neurogastroenterol Motil (2009) 0.80

Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study. PLoS One (2013) 0.79

Evaluating the patient with diarrhea: a case-based approach. Mayo Clin Proc (2012) 0.79

Gut pain & visceral hypersensitivity. Br J Pain (2013) 0.78

Prokinetic effects of large-dose lubiprostone on gastrointestinal transit in dogs and its mechanisms. Am J Transl Res (2015) 0.78

Family history of mental illness or alcohol abuse and the irritable bowel syndrome. J Psychosom Res (2014) 0.78

Natural history of irritable bowel syndrome in women and dysmenorrhea: a 10-year follow-up study. Gastroenterol Res Pract (2012) 0.78

Chronic constipation and co-morbidities: A prospective population-based nested case-control study. United European Gastroenterol J (2015) 0.78

Cost-effectiveness of universal serologic screening to prevent nontraumatic hip and vertebral fractures in patients with celiac disease. Clin Gastroenterol Hepatol (2013) 0.78

Treatment of psychological co-morbidities in common gastrointestinal and hepatologic disorders. World J Gastrointest Pharmacol Ther (2010) 0.77

An Evidence-based Approach to Therapy in IBS-D: A Case Study Compendium. Gastroenterol Hepatol (N Y) (2010) 0.77

Optimal management of chronic cyclical pelvic pain: an evidence-based and pragmatic approach. Int J Womens Health (2010) 0.77

Patient knowledge and perspective on irritable bowel syndrome: development of a survey instrument. Dig Dis Sci (2007) 0.77

Associations between medication use and functional gastrointestinal disorders: a population-based study. Neurogastroenterol Motil (2013) 0.76

Effects of Birth Cohorts on the Irritable Bowel Syndrome Support Early-Life Risk Factors. Dig Dis Sci (2015) 0.76

Inhibition of gastric secretion relieves diarrhea and postprandial urgency associated with irritable bowel syndrome or functional diarrhea. Dig Dis Sci (1999) 0.76

Novel surgery for refractory mixed constipation: Jinling procedure - technical notes and early outcome. Arch Med Sci (2014) 0.75

Mesalazine Has No Effect on Mucosal Immune Biomarkers in Patients with Diarrhea-Dominant Irritable Bowel Syndrome Referred to Shariati Hospital: A Randomized Double-Blind, Placebo-Controlled Trial. Middle East J Dig Dis (2017) 0.75

Genetic diversity contributes to abnormalities in pain behaviors between young and old rats. Age (Dordr) (2011) 0.75

Irritable Bowel Syndrome and Bronchial Asthma: Are They Associated in Indian Population? J Clin Diagn Res (2017) 0.75

Articles by these authors

The diagnosis of osteoporosis. J Bone Miner Res (1994) 10.90

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med (1998) 9.43

Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med (1994) 9.25

Hip fractures in the elderly: a world-wide projection. Osteoporos Int (1992) 9.08

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51

Involutional osteoporosis. N Engl J Med (1986) 8.20

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med (2000) 7.62

Psychotropic drug use and the risk of hip fracture. N Engl J Med (1987) 7.53

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44

The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone (1995) 5.76

A clinical trial of a chest-pain observation unit for patients with unstable angina. Chest Pain Evaluation in the Emergency Room (CHEER) Investigators. N Engl J Med (1998) 5.67

Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54

Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med (1990) 5.49

Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) (1982) 5.29

A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. Am Rev Respir Dis (1992) 5.22

Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA (1996) 5.17

A meta-analysis of previous fracture and subsequent fracture risk. Bone (2004) 4.92

Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology (1992) 4.84

Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res (1992) 4.75

Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 4.74

Population-based study of survival after osteoporotic fractures. Am J Epidemiol (1993) 4.71

Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut (1990) 4.60

Simplified assessment of segmental colonic transit. Gastroenterology (1987) 4.59

Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology (1998) 4.52

Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology (2007) 4.28

Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab (1998) 4.28

A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res (1998) 4.24

Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology (1993) 4.23

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology (1993) 4.18

Surgical management of Meckel's diverticulum. An epidemiologic, population-based study. Ann Surg (1994) 4.16

A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology (1990) 4.02

Potential effect of authorization bias on medical record research. Mayo Clin Proc (1999) 4.01

The prevention and treatment of osteoporosis. N Engl J Med (1992) 3.90

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology (2001) 3.85

Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology (1990) 3.77

The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology (2001) 3.60

Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest (1981) 3.60

A patient questionnaire to identify bowel disease. Ann Intern Med (1989) 3.43

Thoracic aortic aneurysms: a population-based study. Surgery (1982) 3.36

Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc (1990) 3.34

A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc (1994) 3.14

Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults. Radiology (1989) 3.12

Smoking and fracture risk: a meta-analysis. Osteoporos Int (2004) 3.08

Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis. Ann Neurol (1995) 3.06

Incidence of spontaneous pneumothorax in Olmsted County, Minnesota: 1950 to 1974. Am Rev Respir Dis (1979) 3.06

Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int (2011) 3.04

Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology (1993) 2.99

Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med (1999) 2.98

Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation (1989) 2.94

Epidemiology of fractures of the proximal femur in Rochester, Minnesota. Clin Orthop Relat Res (1981) 2.93

Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest (1982) 2.92

Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89

Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut (2000) 2.86

Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum (1984) 2.85

Medical costs in community subjects with irritable bowel syndrome. Gastroenterology (1995) 2.81

Epidemiologic features of humeral fractures. Clin Orthop Relat Res (1982) 2.79

Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med (2000) 2.77

Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75

Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int (2008) 2.74

Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int (2008) 2.72

The Neurobehavioral Cognitive Status Examination: a brief but quantitative approach to cognitive assessment. Ann Intern Med (1987) 2.58

Temporal lobe seizures: lateralization with MR volume measurements of the hippocampal formation. Radiology (1990) 2.56

Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol (1992) 2.54

Long-term survival of a cohort of community residents with asthma. N Engl J Med (1994) 2.47

Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab (2001) 2.43

Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res (1999) 2.37

Osteoporosis and the risk of hip fracture. Am J Epidemiol (1986) 2.35

Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (1991) 2.35

Sex differences in evaluation and outcome of unstable angina. JAMA (2000) 2.33

A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol (2000) 2.27

Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol (1989) 2.24

Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med (1982) 2.23

PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut (2005) 2.22

Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology (2007) 2.22

Evidence for two distinct syndromes of involutional osteoporosis. Am J Med (1983) 2.17

Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology (1992) 2.17

Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clin Proc (2001) 2.17

Incidence of Colles' fracture in a North American community. Am J Public Health (1982) 2.17

Outcomes of surgery in patients 90 years of age and older. JAMA (1989) 2.15

Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther (2015) 2.13

A family history of fracture and fracture risk: a meta-analysis. Bone (2004) 2.13

Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology (1994) 2.12

Validating biomarkers of treatable mechanisms in irritable bowel syndrome. Neurogastroenterol Motil (2014) 2.11

Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 2.11

Trends in the utilization of primary total hip arthroplasty, 1969 through 1990: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc (1993) 2.10

Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome. Gastroenterology (1990) 2.09

Severe exercise-induced ischemia does not identify high risk patients with normal left ventricular function and one- or two-vessel coronary artery disease. J Am Coll Cardiol (1994) 2.08

Clinical predictors of recurrent Clostridium difficile infection in out-patients. Aliment Pharmacol Ther (2014) 2.08